Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Marts 2019

Planlagt Fastgjort Låst Flyttet Genmab
1.2k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • P Offline
    P Offline
    Parasitism
    wrote on sidst redigeret af
    #970

    God morgen 🙂

    1 Reply Last reply
    0
    • J Offline
      J Offline
      JohnW
      wrote on sidst redigeret af
      #971

      Investtech: Genmab har brudt op gennem loftet i en faldende trendkanal på mellemlang sigt. Dette indikerer i første omgang svagere faldende takt, eller indledning til en mere horisontal udvikling. Aktien gav købssignal fra en omvendt-hovede-og-skuldre-formation ved bruddet op gennem modstanden ved 1103. Videre stigning til 1571 eller mere er signaleret. Aktien nærmer sig støtten ved cirka 1110 kroner, noget der kan give en reaktion op. Aktien anses samlet set teknisk positiv på mellemlang sigt.

      1 Reply Last reply
      0
      • J Offline
        J Offline
        JohnW
        wrote on sidst redigeret af
        #972

        Anbefaling: Køb

        1 Reply Last reply
        0
        • T Offline
          T Offline
          transalp
          wrote on sidst redigeret af
          #973

          Go morgen 🙂

          1 Reply Last reply
          0
          • L Offline
            L Offline
            lahn1
            wrote on sidst redigeret af
            #974

            07:11 - godt de har styr på det

            1 Reply Last reply
            0
            • J Offline
              J Offline
              Jazzz
              wrote on sidst redigeret af
              #975

              Ikke en hel skidt dag at have NOVO, Genmab og Zealand aktier..

              1 Reply Last reply
              0
              • J Offline
                J Offline
                JKY_VH
                wrote on sidst redigeret af
                #976

                Jep, det er bedre end B&O

                1 Reply Last reply
                0
                • H Offline
                  H Offline
                  HTH
                  wrote on sidst redigeret af
                  #977

                  Genmab Announces Submission of Supplemental Biologics License Application to FDA for Daratumumab in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma

                  1 Reply Last reply
                  0
                  • BulderB Offline
                    BulderB Offline
                    Bulder
                    wrote on sidst redigeret af
                    #978

                    Tilsyneladende ikke RTOR for Cass.

                    1 Reply Last reply
                    0
                    • S Offline
                      S Offline
                      Sukkeralf
                      wrote on sidst redigeret af
                      #979

                      Nu er det også en kombination der bruges i Europa, så heller ikke forventet at få RTOR på den

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #980

                        great. let's hope european application can follow soon so we can get to the transplant eligible patients

                        1 Reply Last reply
                        0
                        • T Offline
                          T Offline
                          transalp
                          wrote on sidst redigeret af
                          #981

                          Go morgen.. 🙂

                          1 Reply Last reply
                          0
                          • BulderB Offline
                            BulderB Offline
                            Bulder
                            wrote on sidst redigeret af
                            #982

                            Novatis Mayzent : https://www.reuters.com/article/us-fda-mayzent/novartis-gets-u-s-approval-for-new-drug-to-treat-multiple-sclerosis-idUSKCN1R8019

                            1 Reply Last reply
                            0
                            • BulderB Offline
                              BulderB Offline
                              Bulder
                              wrote on sidst redigeret af
                              #983

                              Link Preview Image
                              Novartis receives FDA approval for Mayzent® (siponimod), the first oral drug to treat secondary progressive MS with active disease

                              favicon

                              Novartis (www.novartis.com)

                              1 Reply Last reply
                              0
                              • B Offline
                                B Offline
                                bibob
                                wrote on sidst redigeret af
                                #984

                                Også Celgene i MS. Der er kamp om det. https://m.firstwordpharma.com/hot-heels-eu-application-celgene-files-us-clearance-ozanimod-relapsing-multiple-sclerosis

                                1 Reply Last reply
                                0
                                • P Offline
                                  P Offline
                                  Parasitism
                                  wrote on sidst redigeret af
                                  #985

                                  God morgen 🙂

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #986

                                    from recent Conference, Tisotumab vedotin
                                    https://www.mdedge.com/hematology-oncology/article/197472/gynecologic-cancer/tisotumab-vedotin-shows-promise-recurrent

                                    1 Reply Last reply
                                    0
                                    • P Offline
                                      P Offline
                                      polle1
                                      wrote on sidst redigeret af
                                      #987

                                      Godmorgen og god dag

                                      1 Reply Last reply
                                      0
                                      • B Offline
                                        B Offline
                                        bibob
                                        wrote on sidst redigeret af
                                        #988

                                        @pensionisten. Jeg håber at din kone må få nye og bedre behandlingsmuligheder. Der kommer heldigvis nye og forhåbentlig bedre medicin på markedet. Held og lykke. 🙂

                                        1 Reply Last reply
                                        0
                                        • J Offline
                                          J Offline
                                          JKY_VH
                                          wrote on sidst redigeret af
                                          #989

                                          Også H&L herfra og god morgen:-)

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger